Nicotinamide 用于 紫外线防护(内源性光防护)
A 证据 多项大型临床试验一致显示出显著的益处。At chemoprevention doses (1,000 mg/day), oral nicotinamide replenishes UV-depleted NAD+ stores, enhancing cellular energy for DNA repair and supporting immune surveillance of UV-damaged cells (ONTRAC Phase 3 trial).
结论
At chemoprevention doses (1,000 mg/day), oral nicotinamide replenishes UV-depleted NAD+ stores, enhancing cellular energy for DNA repair and supporting immune surveillance of UV-damaged cells (ONTRAC Phase 3 trial).
Key Study Findings
研究人群: Overview of reviews on niacin/nicotinamide adverse effects
研究人群: High-risk NMSC patients (RCTs)
研究人群: None
研究人群: General population (cosmetic users)
Key Statistics
5
研究数量
686
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- generalskinbarrier:
- 500-1,500 mg/day
- skincancerchemoprevention:
- 500 mg twice daily (1,000 mg/day total)
上限: Generally well-tolerated up to 3,000 mg/day (no flushing unlike niacin)
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Mixed | -- |
| Nicotinamide (vitamin B3) | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Mixed | -- |
| Niacinamide up to 5%; Niacin up to 0.1% | -- | Mixed | -- |
最佳服用时间: With meals; split into 2 doses for chemoprevention
Safety & Side Effects
已报告的副作用
- ⚠ Generally well-tolerated (no flushing)
- ⚠ Mild gastrointestinal discomfort at high doses
- ⚠ Rare hepatotoxicity at very high doses
已知相互作用
- ● Anticonvulsants (carbamazepine — may increase levels)
- ● Isoniazid (competes for NAD+ pathways)
- ● Hepatotoxic drugs (potential additive liver effect at high doses)
可耐受最高摄入量: Generally well-tolerated up to 3,000 mg/day (no flushing unlike niacin)
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Nicotinamide help with 紫外线防护(内源性光防护)?
How much Nicotinamide should I take for 紫外线防护(内源性光防护)?
Are there side effects of Nicotinamide?
How strong is the evidence for Nicotinamide and 紫外线防护(内源性光防护)?
Related Evidence
其他成分用于 紫外线防护(内源性光防护)
References
- [1] Su Ling Young et al.. Eye (Lond). 2025. The adverse effects of oral niacin/nicotinamide - an overview of reviews. doi:10.1038/s41433-025-04027-2 PubMed
- [2] Giulio Tosti et al.. Nutrients. 2023. The Role of Nicotinamide as Chemo-Preventive Agent in NMSCs: A Systematic Review and Meta-Analysis. doi:10.3390/nu16010100 PubMed
- [3] Katherine G Thompson et al.. J Am Acad Dermatol. 2021. Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium. doi:10.1016/j.jaad.2020.04.123 PubMed
- [4] Reed Huber et al.. Skin Therapy Lett. 2020. Nicotinamide: An Update and Review of Safety & Differences from Niacin. PubMed
- [5] Cosmetic Ingredient Review Expert Panel. Int J Toxicol. 2005. Final report of the safety assessment of niacinamide and niacin. doi:10.1080/10915810500434183 PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。